Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 1
2007 2
2009 1
2010 3
2011 1
2012 4
2013 5
2014 9
2015 12
2016 3
2017 7
2018 9
2019 10
2020 11
2021 11
2022 15
2023 5
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination.
Strezova A, Diez-Domingo J, Al Shawafi K, Tinoco JC, Shi M, Pirrotta P, Mwakingwe-Omari A; Zoster-049 Study Group. Strezova A, et al. Open Forum Infect Dis. 2022 Oct 23;9(10):ofac485. doi: 10.1093/ofid/ofac485. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36299530 Free PMC article.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu CJ, Andrews C, Beytout J, Caso C, Cheng HS, Cheong HJ, Choo EJ, Curiac D, Di Paolo E, Dionne M, Eckermann T, Esen M, Ferguson M, Ghesquiere W, Hwang SJ, Avelino-Silva TJ, Kosina P, Liu CS, Markkula J, Moeckesch B, Murta de Oliveira C, Park DW, Pauksens K, Pirrotta P, Plassmann G, Pretswell C, Rombo L, Salaun B, Sanmartin Berglund J, Schenkenberger I, Schwarz T, Shi M, Ukkonen B, Zahaf T, Zerbini C, Schuind A, Cunningham AL; Zoster-049 Study Group. Boutry C, et al. Clin Infect Dis. 2022 Apr 28;74(8):1459-1467. doi: 10.1093/cid/ciab629. Clin Infect Dis. 2022. PMID: 34283213 Free PMC article. Clinical Trial.
Migraine as a Cortical Brain Disorder.
Barbanti P, Brighina F, Egeo G, Di Stefano V, Silvestro M, Russo A. Barbanti P, et al. Headache. 2020 Oct;60(9):2103-2114. doi: 10.1111/head.13935. Epub 2020 Aug 26. Headache. 2020. PMID: 32851650 Review.
Dopaminergic symptoms in migraine.
Barbanti P, Fofi L, Aurilia C, Egeo G. Barbanti P, et al. Neurol Sci. 2013 May;34 Suppl 1:S67-70. doi: 10.1007/s10072-013-1415-8. Neurol Sci. 2013. PMID: 23695049 Review.
Botulinum Neurotoxin for the Treatment of Neuropathic Pain.
Egeo G, Fofi L, Barbanti P. Egeo G, et al. Among authors: barbanti p. Front Neurol. 2020 Aug 11;11:716. doi: 10.3389/fneur.2020.00716. eCollection 2020. Front Neurol. 2020. PMID: 32849195 Free PMC article. Review.
Genetic bases of the nutritional approach to migraine.
De Marchis ML, Guadagni F, Silvestris E, Lovero D, Della-Morte D, Ferroni P, Barbanti P, Palmirotta R. De Marchis ML, et al. Among authors: barbanti p. Crit Rev Food Sci Nutr. 2019;59(14):2308-2320. doi: 10.1080/10408398.2018.1450215. Epub 2018 Apr 3. Crit Rev Food Sci Nutr. 2019. PMID: 29517920 Review.
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.
Barbanti P, Egeo G, Aurilia C, Altamura C, d'Onofrio F, Finocchi C, Albanese M, Aguggia M, Rao R, Zucco M, Frediani F, Filippi M, Messina R, Cevoli S, Carnevale A, Fiorentini G, Messina S, Bono F, Torelli P, Proietti S, Bonassi S, Vernieri F; Italian Migraine Registry study group. Barbanti P, et al. J Headache Pain. 2022 Nov 1;23(1):138. doi: 10.1186/s10194-022-01498-6. J Headache Pain. 2022. PMID: 36316648 Free PMC article.
108 results